Skip to main content

Table 1 Demographic and clinical variables

From: Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study

Characteristics

Mean ± SD (%) [range]

Age (years)

61.6 ± 12.6 [26–87]

Female

56 (36.1)

HTN

41 (26.5)

DM

18 (11.6)

CAD

17 (11.0)

Weight (kg)

59.1 ± 9.3 [40.0–85.0]

Height (m)

1.63 ± 7.5 [1.40–1.80]

BMI (kg/m2)

22.1 ± 3.0 [16.1–29.5]

CEA (ng/mL)

61.6 ± 12.6 [26–87]

Length of stay (days)

24.0 ± 8.1 [7–69]

Blood loss (ml)

174.1 ± 407.9 [10–4500]

SMI (cm2/m2)

40.5 ± 14.4 [17.6–79.7]

SMD (HU)

38.2 ± 13.5 [9.6–76.6]

VFA (cm2)

111.1 ± 33.2 [50.6–200.1]

MFA (cm2)

17.1 ± 8.9 [5.5–34.2]

Per-op CCRTx

25 (16.1)

Post-op CCRTx

79 (51.0)

TNM stage

 

I/II/III/IV

27(17.4)/60(38.7)/68(43.9)/10(5.6)

ASA grade

 

1/2/3

63(40.6)/70(45.2)/22(14.2)

Complications

 

None/ Minor/ Major

87(56.1)/40(25.8)/28(18.1)

  1. ASA American Society of Anesthesiologists, BMI body mass index, CAD coronary heart disease, CCRTx chemoradiation therapy, CEA carcinoembryonic antigen, DM diabetes mellitus, HTN hypertension, MFA area of mesorectal fat, SMD skeletal muscle radiodensity, SMI skeletal muscle index, TNM tumor-node-metastasis, VFA area of visceral fat
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us